FDA Approves First Generic Version of Tamiflu

Share this content:
FDA Approves First Generic Version of Tamiflu
FDA Approves First Generic Version of Tamiflu

MONDAY, Aug. 8, 2016 (HealthDay News) -- The first generic version of the flu medication Tamiflu has been approved by the U.S. Food and Drug Administration.

Tamiflu (oseltamivir phosphate) is used to treat patients 2 weeks of age and older who have had flu symptoms for no more than 48 hours. It's also used for the prevention of flu in patients 1 year of age and older. The FDA approved Tamiflu in 1999.

Oseltamivir phosphate does not take the place of seasonal flu vaccination, the FDA emphasized.

The agency also said oseltamivir phosphate does not treat or prevent illnesses caused by infections other than the flu virus, and does not prevent bacterial infections that may happen with the flu.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Belimumab Aids Anti-dsDNA, Hypocomplementemic Lupus

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group

Too Few Adults Taking Epilepsy Meds Have Seizure Control

Too Few Adults Taking Epilepsy Meds Have Seizure ...

Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control

Pediatric Exposures to Liquid Nicotine Down From 2015 to 2016

Pediatric Exposures to Liquid Nicotine Down From 2015 ...

Still poses serious risk to children; decrease likely in part to law requiring child-resistant packaging

is free, fast, and customized just for you!

Already a member?

Sign In Now »